CD33 and acute myeloid leukemia: Importantly, CD33-CAR-NK cells efficiently eliminated AML cells in vitro and eradicated all BM- and spleen-infiltrating as well as the majority of peripheral AML cells in NSG-SGM3 mice without observable side effects.